MedTrace Logo

Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer

NCT05927818 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-11-25

No results posted yet for this study

Summary

The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing it to the results obtained from systematic lymphadenectomy, each performed in participants with a suspicious adnexal mass for early-stage ovarian cancer.

Conditions

  • Sentinel Lymph Node
  • Ovarian Carcinoma

Interventions

DIAGNOSTIC_TEST

Sentinel lymph node biopsy (using sterile charcoal stain) in early ovarian cancer

Described in previous sections

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-15
Primary Completion
2025-10-15
Completion
2026-01-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05927818 on ClinicalTrials.gov